cms glp 1 coverage 📣The Bridge program is scheduled to start on July 1! Are you ready? The Medicare GLP-1 Bridge program marks a historic shift by expanding access to obesity medications for eligible Medicare GLP-1 Weight-Loss Drug Demonstration Begins

Genetic and Metabolic Factors in GLP-1 Selection Emerging research shows that genetic variants in GLP-1 receptor signaling (GLP1R rs6923761), GIPR pathway activation (rs1800437), and metabolic predisposition (FTO rs9939609, MC4R rs17782313) may inform individual treatment response

Clinicians instruct patients to count audible "clicks" on standard GLP-1 pens to give smaller, fractional doses

Eliquis belongs to a class of medications called anticoagulants used to prevent blood clots, and at times treat, blood clots

Personalized Nutrition and Sustainable Weight Loss Microbiome-Targeted Interventions: Digbi Health's program uses 3Gs of personalizationGenetics, Gut microbiome, and Glucose datato tailor dietary recommendations

Nutrients 2024, 16(6)